NextPlat Corp (NXPL) 股票分析
科技NextPlat Corp
$7.11
+$1.01 (+16.56%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
最新新闻
NextPlat Reports Q1 2026 Results: Full Earnings Call Transcript
Benzinga·NextPlat Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35%
Finnhub·Earnings Scheduled For May 14, 2026
Benzinga·
新闻由第三方来源提供。不构成投资建议。
分析
公司概述
NextPlat Corp operates within the technology sector, specifically the software application industry, functioning as a dual-segment enterprise focused on healthcare and e-commerce markets across Europe, North America, South America, the Asia and Pacific regions, and Africa. The company executes its strategy through two distinct operational segments: e-Commerce Operations and Healthcare Operations, which include full-service retail and specialty services pharmacies. This entity maintains a workforce of 162 employees and currently holds a market capitalization of $12.76M, reflecting its position as a small-cap entity with limited overall market weight. With annual revenue reaching $57.15M, the company's valuation metrics indicate that its market value is significantly below its revenue generation, suggesting a market assessment that prioritizes balance sheet strength or future turnaround potential over current profitability. The disparity between its $12.76M market cap and $57.15M revenue highlights a significant discount applied by investors, likely due to the company's substantial net losses and negative earnings trajectory.
财务健康
The company reported total revenue of $57.15M for the trailing twelve months, yet this revenue base supports a net income of -$8,334,000 and an EBITDA of -$7,454,000, revealing a cost structure where operating expenses and non-operating costs substantially exceed gross profit generation. The free cash flow stands at -$2,746,000, indicating that the company's operational cash generation is insufficient to cover capital expenditures and working capital requirements, thereby limiting its immediate financial flexibility for organic expansion without external financing. Margin analysis shows a gross margin of 19.3%, which provides a baseline for cost of goods sold efficiency, but this is eroded by an operating margin of -14.5% and a profit margin of -14.6%, signaling that fixed cost burdens or high administrative overhead are severely impacting bottom-line profitability. In terms of leverage, the company holds $13.93M in cash against $1.72M in debt, resulting in a debt-to-equity ratio of 7.96, which appears high but is mitigated by the substantial cash reserves that provide a liquidity buffer against the reported leverage. The current ratio of 3.56 demonstrates strong short-term liquidity, suggesting the company possesses ample current assets to cover its current liabilities without immediate distress. However, the return on equity of -32.5% and return on assets of -14.4% indicate that management is currently destroying value rather than generating returns on the capital invested by shareholders or creditors.
估值评估
The trailing twelve-month P/E ratio is listed as N/A, and the forward P/E is also N/A, implying that traditional earnings-based valuation models cannot be applied due to the company's persistent net losses, which eliminates any basis for comparing expected earnings trajectories via these multiples. The price-to-book ratio is 0.58, indicating that the market values the company at less than 60% of its net asset value, suggesting a significant discount relative to the book value of its underlying equity. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.22 and an EV/EBITDA of -0.05, which collectively suggest that investors are pricing the stock based on asset backing rather than growth prospects or earnings power. The stock has traded within a 52-week range between $0.41 and $1.11; given the current price metrics relative to these bounds, the asset trades significantly below its recent high, reflecting ongoing market skepticism regarding its path to profitability. The beta of 1.27 indicates that the stock exhibits higher volatility than the broader market, moving approximately 27% more aggressively than the market index in response to general market fluctuations.
Growth & Income
Revenue growth year-over-year has declined by 10.5%, while earnings growth is marked as N/A due to the company's continued losses, indicating that the business is contracting or struggling to stabilize its earnings base rather than expanding faster than its revenue. As a non-dividend payer, the company does not distribute a dividend yield or maintain a payout ratio, which means the firm retains all earnings—though currently negative—to fund operations rather than returning capital to shareholders. The absence of a dividend policy combined with negative revenue growth suggests a growth-and-income profile that is currently driven by asset liquidation or operational contraction rather than profitable reinvestment. Overall, the company presents a profile of a small-cap technology firm facing revenue contraction and significant operational losses, offering no current income stream and relying on its cash reserves to navigate the current period of negative performance.
同行比较
NextPlat Corp (NXPL) 在软件 - 应用程序行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| NextPlat Corp | NXPL | $16.52M | N/A |
| SAP SE | SAP | $206.49B | 24.1 |
| Shopify Inc. | SHOP.TO | $188.02B | 102.8 |
| Salesforce, Inc. | CRM | $146.50B | 22.9 |
软件 - 应用程序行业平均市盈率为45.6倍。NextPlat Corp的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关软件 - 应用程序股票
SAP SE
$206.49B
SHOP.TOShopify Inc.
$188.02B
CRMSalesforce, Inc.
$146.50B
UBERUber Technologies, Inc.
$142.74B
SHOPShopify Inc.
$136.12B
NOWServiceNow, Inc.
$105.33B
科技热门股票
NVIDIA Corporation
$6.77T
AAPL.TOApple Inc.
$5.97T
NVDANVIDIA Corporation
$5.22T
AAPLApple Inc.
$4.53T
MSFT.TOMicrosoft Corporation
$4.10T
关于NextPlat Corp
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, Asia and Pacific, and Africa. It operates through two segments, e-Commerce Operations and Healthcare Operations. The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, medication adherence packaging, contracted pharmacy services, health practice risk management, disease testing, contracted pharmacy, and vaccinations services, as well as supplies prescription medications. It also operates e-commerce websites, as well as third-party e-commerce storefronts that provide mobile satellite services solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and internet of things connectivity services; voice, data communications, internet of things (IoT), and machine-to-machine services; tracking and monitoring services; satellite communications products; GPS enabled emergency locator distress beacons; satellite tracking devices used to monitor the location, movements, and history of anything that moves; and GTCTrack, a subscription-based mapping and tracking portal that provides a universal and hardware-agnostic, cloud-based data visualization and management platform. In addition, the company provides value-added services, such as prior authorization assistance, same-day home-medication delivery, on-site provider consultation services, primary care reporting and analytics, and customized packaging solutions. Further, it offers satellite phones, tracking devices, broadband terminals, messaging plans, and connectivity services. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp was founded in 2008 and is headquartered in Hallandale Beach, Florida.
公司简介以英文显示。
访问官网 →